UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents

Haematologica (Roma), 2012-11, Vol.97 (11), p.1761-1767

2012

Volltextzugriff (PDF)

Effects of long-term nitrogen addition on phosphorus cycling in organic soil horizons of temperate forests

Biogeochemistry, 2018-11, Vol.141 (2), p.167-181

2018

Volltextzugriff (PDF)

Electroless Deposition and Structuring of Silver Electrodes in Closed Microfluidic Capillaries

Journal of microelectromechanical systems, 2011-04, Vol.20 (2), p.451-459

2011

Volltextzugriff (PDF)

Low voltage electroosmotic pump for high density integration into microfabricated fluidic systems

Microfluidics and nanofluidics, 2011-06, Vol.10 (6), p.1317-1332

2011

Volltextzugriff (PDF)

P29 PHASE 1/2 RESULTS OF TALQUETAMAB, A G PROTEIN‐COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) (MONUMENTAL‐1)

HemaSphere, 2023-05, Vol.7 (S2), p.26-27

2023

Volltextzugriff (PDF)

AB1194 Serum cartilage oligomeric matrix protein compared to articular cartilage thickness in children with juvenile idiopathic arthritis

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.706-706

2013

Volltextzugriff (PDF)

OP0012 Chronic recurrent non-bacterial osteomyelitis in danish children

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.56-56

2013

Volltextzugriff (PDF)

Establishing traceability of photometric absorbance values for accurate measurements of the haemoglobin concentration in blood

Metrologia, 2013-10, Vol.50 (5), p.539-548

2013

Volltextzugriff (PDF)

Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma

Haematologica (Roma), 2013-07, Vol.98 (7), p.1147-1153

2013

Volltextzugriff (PDF)

Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma

Blood cancer journal (New York), 2016-07, Vol.6 (7), p.e453-e453

2016

Volltextzugriff (PDF)

Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma

Blood cancer journal (New York), 2016-09, Vol.6 (9), p.e471

2016

Volltextzugriff (PDF)

S170: DYNAMIC INTERPLAY BETWEEN TUMOR AND MICRO‐ENVIRONMENT DURING MYELOMA DISEASE PROGRESSION

HemaSphere, 2022-06, Vol.6, p.71-72

2022

Volltextzugriff (PDF)

An Analytical Approach for Performance Evaluation of Hybrid (Broadcast/Mobile) Networks

IEEE transactions on broadcasting, 2010-03, Vol.56 (1), p.9-18

Heuck, C.

2010

Volltextzugriff (PDF)

A randomised controlled trial of short term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide

Archives of disease in childhood, 2000-10, Vol.83 (4), p.334-339

2000

Volltextzugriff (PDF)

Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results

Journal of cancer research and clinical oncology, 2021-02, Vol.147 (2), p.619-631

2021

Volltextzugriff (PDF)

Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120)

Haematologica (Roma), 2015-09, Vol.100 (9), p.1214-1221

2015

Volltextzugriff (PDF)

Assessment of the relation between short and intermediate term growth in children with asthma treated with inhaled glucocorticoids

Allergy (Copenhagen), 2004-11, Vol.59 (11), p.1193-1197

2004

Volltextzugriff (PDF)

Circadian variations in serum eosinophil cationic protein, and serum and urine eosinophil protein X

Pediatric allergy and immunology, 2003-04, Vol.14 (2), p.130-133

2003

Volltextzugriff (PDF)

Changes in articular cartilage thickness of the knee in JIA as assessed by ultrasonography

Pediatric rheumatology online journal, 2011-09, Vol.9 (S1), p.P44-P44, Article P44

2011

Volltextzugriff (PDF)

Exposure‐Response and Population Pharmacokinetic Analyses of a Novel Subcutaneous Formulation of Daratumumab Administered to Multiple Myeloma Patients

Journal of clinical pharmacology, 2021-05, Vol.61 (5), p.614-627

2021

Volltextzugriff (PDF)

Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study

Annals of hematology, 2021-04, Vol.100 (4), p.1065-1077

2021

Volltextzugriff (PDF)

Reduced SMAD7 Leads to Overactivation of TGF-β Signaling in MDS that Can Be Reversed by a Specific Inhibitor of TGF-β Receptor I Kinase

Cancer research (Chicago, Ill.), 2011-02, Vol.71 (3), p.955-963

2011

Volltextzugriff (PDF)

1 – 25 von 304

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Zeitschrift / SerieLeukemia

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(226)
Mit Volltextzugriff
(188)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(169)
EZB Electronic Journals Library
(107)
Ingenta
(86)
Journals@Ovid Full Text
(80)
Single Journals
(61)
Springer journals
(58)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(43)
Wiley Online Library Journals
(32)
Wiley Online Library
(27)
Thieme Connect Journals
(25)
IngentaConnect Journals
(19)
Oxford journals
(15)
Oxford Journals 2020 Medicine
(14)
JSTOR
(11)
HEAL-Link subscriptions: Springer Book Series
(11)
Taylor & Francis:Master (3349 titles)
(10)
Nature
(10)
Taylor & Francis Journals
(10)
Taylor & Francis
(10)
Ebook Central Perpetual and DDA
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents

Effects of long-term nitrogen addition on phosphorus cycling in organic soil horizons of temperate forests

Electroless Deposition and Structuring of Silver Electrodes in Closed Microfluidic Capillaries

Low voltage electroosmotic pump for high density integration into microfabricated fluidic systems

P29 PHASE 1/2 RESULTS OF TALQUETAMAB, A G PROTEIN‐COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) (MONUMENTAL‐1)

AB1194 Serum cartilage oligomeric matrix protein compared to articular cartilage thickness in children with juvenile idiopathic arthritis

P42 HEALTH‐RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH TALQUETAMAB, A G PROTEIN‐COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, FROM MONUMENTAL‐1

OP0012 Chronic recurrent non-bacterial osteomyelitis in danish children

Establishing traceability of photometric absorbance values for accurate measurements of the haemoglobin concentration in blood

Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma

Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma

Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma

S170: DYNAMIC INTERPLAY BETWEEN TUMOR AND MICRO‐ENVIRONMENT DURING MYELOMA DISEASE PROGRESSION

Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial

An Analytical Approach for Performance Evaluation of Hybrid (Broadcast/Mobile) Networks

Final analysis of the phase III non-inferiority COLUMBA study of subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma

A randomised controlled trial of short term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide

Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results

Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120)

Assessment of the relation between short and intermediate term growth in children with asthma treated with inhaled glucocorticoids

Circadian variations in serum eosinophil cationic protein, and serum and urine eosinophil protein X

Changes in articular cartilage thickness of the knee in JIA as assessed by ultrasonography

Exposure‐Response and Population Pharmacokinetic Analyses of a Novel Subcutaneous Formulation of Daratumumab Administered to Multiple Myeloma Patients

Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study

Reduced SMAD7 Leads to Overactivation of TGF-β Signaling in MDS that Can Be Reversed by a Specific Inhibitor of TGF-β Receptor I Kinase

Aktive Filter

Suchergebnisse filtern